Craft

Spectral Medical

Stock Price

$0.6

2024-10-29

Market Capitalization

$168.7 M

2024-10-29

Revenue

$2.4 M

FY, 2025

Spectral Medical Summary

Company Summary

Overview
Spectral Medical is a medical device company developing solutions for the treatment of patients with septic shock and endotoxemia. Its main product is PMX (Toraymyxin), a therapeutic hemoperfusion device that removes circulating endotoxin from the bloodstream.
Type
Public
Status
Active
Founded
1991
HQ
Toronto, CA | view all locations
Website
https://spectraldx.com/
Cybersecurity rating
Sectors

Key People

  • Chris Seto, Chief Executive Officer

    • Paul Walker, Director, President & Chief Executive Officer

      • Jun Hayakawa, Director

        • William Stevens, Director

          LocationsView all

          1 location detected

          • Toronto, ON HQ

            Canada

            135 The West Mall #2, Etobicoke

          Spectral Medical Financials

          Summary Financials

          Revenue (Q1, 2026)
          $C891.0K
          Gross profit (Q1, 2026)
          $C591.0K
          Net income (Q1, 2026)
          ($C2.9M)
          Cash (Q1, 2026)
          $C1.9M
          EBIT (Q1, 2026)
          ($C3.4M)
          Enterprise value
          $184.6M

          Footer menu